Literature DB >> 34299204

Photobiomodulation by Near-Infrared 980-nm Wavelengths Regulates Pre-Osteoblast Proliferation and Viability through the PI3K/Akt/Bcl-2 Pathway.

Dimitrios Agas1, Reem Hanna2,3, Stefano Benedicenti3, Nicola De Angelis3, Maria Giovanna Sabbieti1, Andrea Amaroli3,4.   

Abstract

BACKGROUND: bone tissue regeneration remains a current challenge. A growing body of evidence shows that mitochondrial dysfunction impairs osteogenesis and that this organelle may be the target for new therapeutic options. Current literature illustrates that red and near-infrared light can affect the key cellular pathways of all life forms through interactions with photoacceptors within the cells' mitochondria. The current study aims to provide an understanding of the mechanisms by which photobiomodulation (PBM) by 900-nm wavelengths can induce in vitro molecular changes in pre-osteoblasts.
METHODS: The PubMed, Scopus, Cochrane, and Scholar databases were used. The manuscripts included in the narrative review were selected according to inclusion and exclusion criteria. The new experimental set-up was based on irradiation with a 980-nm laser and a hand-piece with a standard Gaussian and flat-top beam profile. MC3T3-E1 pre-osteoblasts were irradiated at 0.75, 0.45, and 0.20 W in continuous-wave emission mode for 60 s (spot-size 1 cm2) and allowed to generate a power density of 0.75, 0.45, and 0.20 W/cm2 and a fluence of 45, 27, and 12 J/cm2, respectively. The frequency of irradiation was once, three times (alternate days), or five times (every day) per week for two consecutive weeks. Differentiation, proliferation, and cell viability and their markers were investigated by immunoblotting, immunolabelling, fluorescein-FragELTM-DNA, Hoechst staining, and metabolic activity assays. RESULTS AND
CONCLUSIONS: The 980-nm wavelength can photobiomodulate the pre-osteoblasts, regulating their metabolic schedule. The cellular signal activated by 45 J/cm2, 0.75 W and 0.75 W/cm2 consist of the PI3K/Akt/Bcl-2 pathway; differentiation markers were not affected, nor do other parameters seem to stimulate the cells. Our previous and present data consistently support the window effect of 980 nm, which has also been described in extracted mitochondria, through activation of signalling PI3K/Akt/Bcl-2 and cyclin family, while the Wnt and Smads 2/3-β-catenin pathway was induced by 55 J/cm2, 0.9 W and 0.9 W/cm2.

Entities:  

Keywords:  apoptosis; bone differentiation; bone regeneration; light therapy; low-level laser therapy; mechanotransduction; osteoblast; photo-therapy; photobiomodulation; proliferation

Year:  2021        PMID: 34299204     DOI: 10.3390/ijms22147586

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  4 in total

Review 1.  Efficacy of photobiomodulation therapy on healing of ionizing irradiated bone: a systematic review of in vivo animal studies.

Authors:  Samanta Vicente de Oliveira; Thaís Dos Reis; Juliana Amorim; Flaviana Soares Rocha; Márcia Martins Marques; Eliete Silva Guerra; Reem Hanna; Camila Barros Gallo
Journal:  Lasers Med Sci       Date:  2022-10-04       Impact factor: 2.555

Review 2.  Steering the multipotent mesenchymal cells towards an anti-inflammatory and osteogenic bias via photobiomodulation therapy: How to kill two birds with one stone.

Authors:  Andrea Amaroli; Claudio Pasquale; Angelina Zekiy; Stefano Benedicenti; Andrea Marchegiani; Maria Giovanna Sabbieti; Dimitrios Agas
Journal:  J Tissue Eng       Date:  2022-07-05       Impact factor: 7.940

Review 3.  Cellular Signalling and Photobiomodulation in Chronic Wound Repair.

Authors:  Thobekile S Leyane; Sandy W Jere; Nicolette N Houreld
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

Review 4.  A Narrative Review on Oral and Periodontal Bacteria Microbiota Photobiomodulation, through Visible and Near-Infrared Light: From the Origins to Modern Therapies.

Authors:  Andrea Amaroli; Silvia Ravera; Angelina Zekiy; Stefano Benedicenti; Claudio Pasquale
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.